Retrospective Study
Copyright ©The Author(s) 2025.
World J Radiol. Jun 28, 2025; 17(6): 106682
Published online Jun 28, 2025. doi: 10.4329/wjr.v17.i6.106682
Table 1 Multi-cohort comparison of thyroid lobes characteristics, n (%)
Characteristics
Training cohort
Validation cohort
Temporal test cohort
External test cohort
P valuea
P valueb
P valuec
Groupedn = 264n = 112n = 97n = 810.2030.6050.053
Benign80 (30)26 (23)26 (27)15 (19)
Malignant184 (70)86 (77)71 (73)66 (81)
Gender0.3550.4150.463
Female211 (80)84 (75)73 (75)61 (75)
Male53 (20)28 (25)24 (25)20 (25)
Age (years), median (P25-P75)51.00 (38.75-60.00)48.50 (35.75-58.00)50.00 (41.00-57.00)52.00 (41.00-60.00)0.1000.9440.413
BMI, median (P25-P75)24.46 (22.04-26.30)24.73 (22.18-27.05)24.77 (23.11-26.9)25.01 (24.29-25.78)0.2880.1610.042
Multiple nodules0.5170.5190.036
No148 (56)58 (52)50 (52)34 (42)
Yes116 (44)54 (48)47 (48)47 (58)
Tumor size group0.0950.0010.007
Small (≤ 5 mm)43 (16)29 (26)21 (22)24 (30)
Medium (5-10 mm)99 (38)38 (34)52 (54)33 (41)
Large (> 10 mm)122 (46)45 (40)24 (25)24 (30)
Calcify0.6290.344< 0.001
No192 (73)78 (70)76 (78)42 (52)
Yes72 (27)34 (30)21 (22)39 (48)
Cystic0.7410.399< 0.001
No229 (87)95 (85)88 (91)38 (47)
Yes35 (13)17 (15)9 (9)43 (53)
FT3 (pmol/L), median (P25-P75)4.76 (4.39-5.09)4.76 (4.44-4.99)4.71 (4.46-5.03)4.79 (4.32-5.45)0.8910.9180.299
FT4 (pmol/L), median (P25-P75)16.20 (14.88-17.90)16.20 (14.57-18.30)17.40 (15.70-19.00)16.80 (14.50-19.60)0.9760.0020.204
TSH (mU/L), median (P25-P75)1.73 (1.37-2.44)1.62 (1.13-2.59)2.16 (1.38-2.67)1.68 (1.04-3.01)0.0980.1530.665
TGAb (IU/mL), median (P25-P75)16.70 (15.4-21.45)16.70 (15.3-17.72)17.00 (15.81-17.90)17.80 (17.30-18.10)0.1730.7890.001
TPOAb (IU/mL), median (P25-P75)13.00 (12.35-13.22)13.00 (11.35-15.10)15.00 (14.20-15.74)12.60 (12.10-13.50)0.707< 0.001< 0.001